Clinical Trial OPEN: Liver-Targeted Insulin More Effective than Insulin?
Trial name: Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects Diabetes type: Type 1 diabetes What the trial is testing: This six-month study will test the safety and efficacy of HDV insulin, a new technology that directs meal-time rapid-acting insulin...
AFREZZA is BACK!
Afrezza is BACK! After Sanofi terminated its marketing partnership with MannKind, MannKind has relaunched its fast-acting inhalable insulin, Afrezza, as reported in DiaTribe.org on 30 August, 2016. I, for one, couldn’t be happier and more relieved. ...
SPOTLIGHT: On The Bonnie Sher Show!
A STAR is BORN! Yup, little ‘ol me! Mr. deMille, I’m ready for my close-up!!! OK, enough! I was honored to be asked to be a T1d Co-Host on The Bonnie Sher Show, broadcast on UBN internet radio/tv, on Thursday, 15 September 2016. Bonnie is a long-time...
WAY OUT THERE: Non-Scientists Try to Break Up Monopoly on Insulin
OK, … this is WAY OUT THERE … or is it? (this is not a recommendation or endorsement) Listen to this podcast from The Pulse, reporting on an Oakland, CA grassroots community lab for biohacking and citizen science. According to their website,...
Savvy Updates: 9/18/2016: Pilots Fit to Fly with Diabetes, Need More T Cells to Stop Type 1 Diabetes, Glooko and Diasend Merge, Medical-grade Wearables White Paper
Commercial airline pilots flying with insulin-controlled diabetes had no incidents of medical incapacitation in more than 18 months of study, researchers reported by the European Association for the Study of Diabetes, 12 September 2016 via MedPageToday.com. The study...
